Skip to main content
Novartis Top Menu
  • Novartis.com
Novartis Foundation LOGO
    • About Us
      • Board of Trustees
        • Joerg Reinhardt, Ph.D.
        • Ann Aerts, M.D.
        • Dr. Jo Ivey Boufford
        • Lutz Hegemann, M.D., Ph.D.
        • John Kahan
        • Prof. Peter Piot, M.D.
      • Our Team
        • Johannes Boch
        • Cristina Haffner
        • Lucy Setian
        • Sarah Des Rosiers
        • Xavier Sutter
      • Our partners
      About Us
    • Transforming population health
      • Cardiovascular population health initiative
      • AI4BetterHearts
      • Health Policy
        • Broadband Commission Working Group on Digital and AI in Health
        • HealthTech Dialogue Hub
        • AI4HealthyCities
      • HealthTech Innovation
        • Brazil COVID-19 response
        • AI4Leprosy
        • HealthTech Hub Africa
      Transforming Population Health
    • Urban Population Health Toolkit
      • Quality of care
      • Ensure access
      • Policy reform
      • Leverage data and digital
      • Intersectoral collaboration
      • Ensure local ownership
      Urban Population Health Toolkit
    • Past programs
      • Better Hearts Better Cities
        • Community-based Hypertension Improvement Project (ComHIP)
        • Communities for Healthy Hearts
        • KaziBantu (Healthy Schools for Healthy Communities)
      • Leprosy and malaria elimination
        • The Leprosy Alert and Response Network System (LEARNS)
        • Leprosy Post-Exposure Prophylaxis (LPEP) program
        • Malaria Targeted Parasite Elimination Strategy
      • Digital Health
        • Ghana Telemedicine
        • Telemedicine Toolkit
        • Integrated e-Diagnostic Approach
      Past Programs
    • Media Center
      • News Archive
      • Media Library
      • Stories
      Media Center
    Homepage
  1. Home
  2. Media Center
  3. Media Library

Innovative Tools and Approaches to End the Transmission of Mycobacterium Leprae

Back to Previous Page
A cover image of the article regarding tools to end the transmission of Mycobacterium leprae
Description

The drive to interrupt M leprae transmission and finally eliminate leprosy is entering a crucial stage. Sustainability, perseverance, and constant innovation will be crucial to the success of a programme to halt transmission of M leprae.

Innovative Tools and Approaches to End the Transmission of Mycobacterium Leprae (PDF 144.79 KB)

Related Items

  • Image of document cover
    Document
    lock
    Leprosy, Publication
    Leprosy Post-exposure Prophylaxis with Single-dose Rifampicin (LPEP): An International Feasibility Programme
  • Cover image of the article regarding the leprosy diagnostic test development
    Document
    lock
    Leprosy, Publication
    Leprosy Diagnostic Test Development As a Prerequisite Towards Elimination: Requirements from the User’s Perspective
  • Cover image of the article about screening and chemoprophylaxis among contacts of leprosy patients
    Document
    lock
    Leprosy, Publication
    An Innovative Approach to Screening and Chemoprophylaxis among Contacts of Leprosy Patients in Low Endemic Settings: Experiences from Cambodia
  • Cover picture of the publication regarding leprosy control in routine settings
    Document
    lock
    Leprosy, Publication
    Minimal Essential Data to Document Contact Tracing and Single Dose Rifampicin (SDR) for Leprosy Control in Routine Settings: A Practical Guide

Novartis Foundation

Navigate Novartis Foundation
  • About Us
  • Transforming Population Health
  • Urban Population Health Toolkit
  • Past Programs
About the Novartis Foundation
  • Board of Trustees
  • Our Partners
  • Our Team
Media Center
  • News Archive
  • Media Library
  • Our Stories
Footer Bottom
© 2022 Novartis Foundation
  • Terms of Use
  • Privacy Policy
  • Cookie Settings
  • Site Map
Novartis Site Directory
This site is intended for a global audience